Positive News SentimentPositive NewsNASDAQ:APYX Apyx Medical (APYX) Stock Forecast, Price & News $3.22 -0.10 (-3.01%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$3.20▼$3.4550-Day Range$3.22▼$6.2052-Week Range$1.31▼$7.97Volume154,261 shsAverage Volume74,877 shsMarket Capitalization$111.54 millionP/E RatioN/ADividend YieldN/APrice Target$7.88 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Apyx Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside144.6% Upside$7.88 Price TargetShort InterestBearish9.44% of Float Sold ShortDividend StrengthN/ASustainability-1.07Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$113,400 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($0.38) to ($0.49) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.21 out of 5 starsMedical Sector372nd out of 962 stocksSurgical & Medical Instruments Industry47th out of 97 stocks 3.4 Analyst's Opinion Consensus RatingApyx Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.88, Apyx Medical has a forecasted upside of 144.6% from its current price of $3.22.Amount of Analyst CoverageApyx Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted9.44% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 10.6, which indicates bearish sentiment.Change versus previous monthShort interest in Apyx Medical has recently decreased by 16.67%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApyx Medical has received a 60.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.Environmental SustainabilityThe Environmental Impact score for Apyx Medical is -1.07. Previous Next 3.3 News and Social Media Coverage News SentimentApyx Medical has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.Search Interest2 people have searched for APYX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Apyx Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $113,400.00 in company stock.Percentage Held by Insiders13.10% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions59.63% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Apyx Medical are expected to decrease in the coming year, from ($0.38) to ($0.49) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -6.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -6.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Apyx Medical (NASDAQ:APYX) StockApyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Read More APYX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APYX Stock News HeadlinesSeptember 17, 2023 | americanbankingnews.comShort Interest in Apyx Medical Co. (NASDAQ:APYX) Drops By 16.7%August 15, 2023 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Call TranscriptSeptember 24, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...August 12, 2023 | msn.comPiper Sandler Maintains Apyx Medical (APYX) Overweight RecommendationAugust 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and MiNK Therapeutics (INKT)August 11, 2023 | finance.yahoo.comQ2 2023 Apyx Medical Corp Earnings CallAugust 11, 2023 | marketwatch.comStocks to Watch: Cano Health, Maxeon Solar, Apyx MedicalAugust 11, 2023 | marketwatch.comApyx Medical Shares Sink 16% After Sales Miss EstimatesSeptember 24, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...August 11, 2023 | finance.yahoo.comApyx Medical (APYX) Reports Q2 Loss, Misses Revenue EstimatesAugust 10, 2023 | msn.comApyx Medical GAAP EPS of -$0.03 beats by $0.04, revenue of $13.6M misses by $0.75MAugust 10, 2023 | finance.yahoo.comApyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial OutlookAugust 8, 2023 | msn.comPerrigo (PRGO) Q2 Earnings and Revenues Beat EstimatesAugust 2, 2023 | finance.yahoo.comThis Apyx Medical Insider Increased Their Holding By 42% Last YearJuly 27, 2023 | finance.yahoo.comBOV.SG - Apyx Medical CorpJuly 25, 2023 | finance.yahoo.comAPYX - Apyx Medical CorporationJuly 17, 2023 | markets.businessinsider.comLake Street Keeps Their Buy Rating on NeuroPace (NPCE)July 14, 2023 | msn.comStephens & Co. Initiates Coverage of Apyx Medical (APYX) with Overweight RecommendationJuly 10, 2023 | msn.comWhy You Should Add Humana (HUM) Stock to Your Portfolio NowJuly 6, 2023 | finance.yahoo.comApyx Medical Corporation's (NASDAQ:APYX) recent 24% pullback adds to one-year year losses, institutional owners may take drastic measuresJuly 5, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Apyx Medical (APYX), Simulations Plus (SLP)June 29, 2023 | finance.yahoo.comApyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023June 22, 2023 | msn.comHere's Why Buying Brookdale (BKD) Stock is a Prudent Move NowJune 20, 2023 | finance.yahoo.comIs Abcam (ABCM) Outperforming Other Medical Stocks This Year?June 14, 2023 | baystreet.caApyx Hails FDA Breakthrough, Shares FlatJune 14, 2023 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Apyx Medical (APYX)June 14, 2023 | marketwatch.comApyx Medical Gets FDA Clearance for Renuvion Micro HandpieceSee More Headlines Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address APYX Company Calendar Last Earnings8/10/2023Today9/24/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:APYX CUSIPN/A CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees276Year FoundedN/APrice Target and Rating Average Stock Price Forecast$7.88 High Stock Price Forecast$10.00 Low Stock Price Forecast$4.50 Forecasted Upside/Downside+144.6%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,180,000.00 Net Margins-34.34% Pretax Margin-38.81% Return on Equity-49.64% Return on Assets-33.56% Debt Debt-to-Equity RatioN/A Current Ratio2.78 Quick Ratio2.19 Sales & Book Value Annual Sales$44.51 million Price / Sales2.51 Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book2.95Miscellaneous Outstanding Shares34,640,000Free Float30,106,000Market Cap$111.54 million OptionableOptionable Beta1.20 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Charles D. Goodwin II (Age 57)Pres, CEO & Director Comp: $505.44kMs. Tara H. Semb (Age 53)CFO, Treasurer & Sec. Comp: $360.05kMr. Moshe Citronowicz (Age 70)Sr. VP Comp: $332.94kMr. Todd Hornsby (Age 47)Exec. VP Comp: $394.78kKey CompetitorsClearPoint NeuroNASDAQ:CLPTKORU Medical SystemsNASDAQ:KRMDHealth Sciences Acquisitions Co. 2NASDAQ:HSAQSight SciencesNASDAQ:SGHTT2 BiosystemsNASDAQ:TTOOView All CompetitorsInsiders & InstitutionsWorth Venture Partners LLCBought 179,691 shares on 8/15/2023Ownership: 0.894%Boothbay Fund Management LLCSold 102,811 shares on 8/15/2023Ownership: 0.116%Scholtz & Company LLCBought 5,000 shares on 8/15/2023Ownership: 0.043%XTX Topco LtdBought 11,469 shares on 8/15/2023Ownership: 0.033%Citadel Advisors LLCBought 900 shares on 8/15/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions APYX Stock - Frequently Asked Questions Should I buy or sell Apyx Medical stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" APYX shares. View APYX analyst ratings or view top-rated stocks. What is Apyx Medical's stock price forecast for 2023? 4 brokers have issued 1-year price objectives for Apyx Medical's shares. Their APYX share price forecasts range from $4.50 to $10.00. On average, they predict the company's share price to reach $7.88 in the next twelve months. This suggests a possible upside of 144.6% from the stock's current price. View analysts price targets for APYX or view top-rated stocks among Wall Street analysts. How have APYX shares performed in 2023? Apyx Medical's stock was trading at $2.34 at the beginning of the year. Since then, APYX stock has increased by 37.6% and is now trading at $3.22. View the best growth stocks for 2023 here. Are investors shorting Apyx Medical? Apyx Medical saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 2,850,000 shares, a drop of 16.7% from the August 15th total of 3,420,000 shares. Based on an average daily volume of 269,300 shares, the days-to-cover ratio is currently 10.6 days. Approximately 9.4% of the shares of the stock are sold short. View Apyx Medical's Short Interest. When is Apyx Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our APYX earnings forecast. How were Apyx Medical's earnings last quarter? Apyx Medical Co. (NASDAQ:APYX) issued its quarterly earnings results on Thursday, August, 10th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.01. The business had revenue of $13.57 million for the quarter, compared to the consensus estimate of $14.25 million. Apyx Medical had a negative trailing twelve-month return on equity of 49.64% and a negative net margin of 34.34%. What guidance has Apyx Medical issued on next quarter's earnings? Apyx Medical updated its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $59.00 million-$62.00 million, compared to the consensus revenue estimate of $59.99 million. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL). What is Apyx Medical's stock symbol? Apyx Medical trades on the NASDAQ under the ticker symbol "APYX." Who are Apyx Medical's major shareholders? Apyx Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Divisadero Street Capital Management LP (6.60%), Royce & Associates LP (4.63%), Pura Vida Investments LLC (2.86%), Cowen Prime Advisors LLC (1.75%), Taylor Frigon Capital Management LLC (1.55%) and BlackRock Inc. (1.55%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby. View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Apyx Medical's stock price today? One share of APYX stock can currently be purchased for approximately $3.22. How much money does Apyx Medical make? Apyx Medical (NASDAQ:APYX) has a market capitalization of $111.54 million and generates $44.51 million in revenue each year. The company earns $-23,180,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. How many employees does Apyx Medical have? The company employs 276 workers across the globe. How can I contact Apyx Medical? Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The official website for the company is www.apyxmedical.com. The company can be reached via phone at (727) 384-2323, via email at investor.relations@apyxmedical.com, or via fax at 800-323-1640. This page (NASDAQ:APYX) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.